Endava Q2 Adj. EPS $0.37 Beats $0.37 Estimate, Sales $27.88M Miss $233.97M Estimate
Portfolio Pulse from Benzinga Newsdesk
Endava (NYSE:DAVA) reported Q2 adjusted EPS of $0.37, slightly beating the $0.37 estimate, but saw a significant decrease in earnings and sales year-over-year. Sales of $27.88M missed the $233.97M estimate by 88.08%, marking an 88.42% decrease from the previous year.
February 29, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Endava reported a slight beat on Q2 EPS estimates but missed sales estimates by a wide margin, indicating a significant year-over-year decline in performance.
The significant miss in sales estimates and the sharp decline in both earnings and sales from the previous year are likely to negatively impact investor sentiment and the stock price in the short term. Despite the EPS slightly beating estimates, the overall financial health as indicated by the sales figures could lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100